The efficiency of a combined injection technique for sentinel lymph node mapping in intermediate‐high‐risk endometrial cancer

2021 ◽  
Author(s):  
Qian Wang ◽  
Bo Wang ◽  
Lulu Wang ◽  
Yu Xue ◽  
Weiwei Shan ◽  
...  
Keyword(s):  
Endometrial Cancer ◽  
Lymph Node ◽  
High Risk ◽  
Sentinel Lymph Node ◽  
Sentinel Lymph Node Mapping ◽  
Injection Technique ◽  
Lymph Node Mapping

scholarly journals Sentinel lymph node mapping accurately identifies positive nodes in women with high risk endometrial cancer

2015 ◽  
Vol 138 ◽  
pp. 3
Author(s):  
P.T. Soliman ◽  
S.N. Westin ◽  
C.C.L. Sun ◽  
S. Dioun ◽  
M. Frumovitz ◽  
...  
Keyword(s):  
Endometrial Cancer ◽  
Lymph Node ◽  
High Risk ◽  
Sentinel Lymph Node ◽  
Sentinel Lymph Node Mapping ◽  
Lymph Node Mapping

scholarly journals A prospective validation study of sentinel lymph node mapping for high-risk endometrial cancer

2017 ◽  
Vol 146 (2) ◽  
pp. 234-239 ◽  
Author(s):  
Pamela T. Soliman ◽  
Shannon N. Westin ◽  
Shayan Dioun ◽  
Charlotte C. Sun ◽  
Elizabeth Euscher ◽  
...  
Keyword(s):  
Endometrial Cancer ◽  
Lymph Node ◽  
High Risk ◽  
Sentinel Lymph Node ◽  
Validation Study ◽  
Sentinel Lymph Node Mapping ◽  
Lymph Node Mapping

scholarly journals Sentinel Lymph Node Mapping in Endometrial Cancer: A Comprehensive Review

2021 ◽  
Vol 11 ◽  
Author(s):  
Lirong Zhai ◽  
Xiwen Zhang ◽  
Manhua Cui ◽  
Jianliu Wang
Keyword(s):  
Endometrial Cancer ◽  
Lymph Node ◽  
High Risk ◽  
Sentinel Lymph Node ◽  
Early Stage ◽  
Sentinel Lymph Node Mapping ◽  
Lymph Node Status ◽  
Lymph Node Mapping ◽  
High Risk Patients ◽  
Risk Patients

Endometrial cancer (EC) is known as a common gynecological malignancy. The incidence rate is on the increase annually. Lymph node status plays a crucial role in evaluating the prognosis and selecting adjuvant therapy. Currently, the patients with high-risk (not comply with any of the following: (1) well-differentiated or moderately differentiated, pathological grade G1 or G2; (2) myometrial invasion< 1/2; (3) tumor diameter < 2 cm are commonly recommended for a systematic lymphadenectomy (LAD). However, conventional LAD shows high complication incidence and uncertain survival benefits. Sentinel lymph node (SLN) refers to the first lymph node that is passed by the lymphatic metastasis of the primary malignant tumor through the regional lymphatic drainage pathway and can indicate the involvement of lymph nodes across the drainage area. Mounting evidence has demonstrated a high detection rate (DR), sensitivity, and negative predictive value (NPV) in patients with early-stage lower risk EC using sentinel lymph node mapping (SLNM) with pathologic ultra-staging. Meanwhile, SLNM did not compromise the patient’s progression-free survival (PFS) and overall survival (OS) with low operative complications. However, the application of SLNM in early-stage high-risk EC patients remains controversial. As revealed by the recent studies, SLNM may also be feasible, effective, and safe in high-risk patients. This review aims at making a systematic description of the progress made in the application of SLNM in the treatment of EC and the relevant controversies, including the application of SLNM in high-risk patients.

Staging of High-Risk Endometrial Cancer With PET/CT and Sentinel Lymph Node Mapping

2015 ◽  
Vol 40 (10) ◽  
pp. 780-785 ◽  
Author(s):  
Mauro Signorelli ◽  
Cinzia Crivellaro ◽  
Alessandro Buda ◽  
Luca Guerra ◽  
Robert Fruscio ◽  
...  
Keyword(s):  
Endometrial Cancer ◽  
Lymph Node ◽  
High Risk ◽  
Sentinel Lymph Node ◽  
Sentinel Lymph Node Mapping ◽  
Lymph Node Mapping ◽  
Pet Ct
Sign in / Sign up

Export Citation Format

Share Document